Eye imaging may help distinguish ALS from Alzheimer’s disease by revealing differences in retinal protein deposits using polarized light.
Early PrimeC treatment slowed functional decline and reduced the risk of death or ALS complications for ALS patients in a ...
A brain implant helps paralyzed patients type on a computer by decoding attempted finger movements. The device enables rapid, ...
When it comes to constantly adapting to the progression of her husband's ALS, columnist Kristin Neva is both an "old-timer" and a student.
Asking for help or giving instructions can feel intimidating, but being pushy helps ensure patients' well-being, says columnist.
Acurastem received a grant to develop ALS therapies targeting SYF2, a regulator of TDP-43, in collaboration with academic research teams.
ALS News Today joins the ALS Network’s ASK ME ALS webinar series as presenting sponsor, offering expert discussions on ALS ...
Amydis has received $2.5 million to continue mapping toxic deposits of TDP-43 in retinal tissue and develop an eye test for ALS.
Chris was diagnosed with ALS in 2024. Before that, he spent 40 years in the oil and gas industry, working and living in eight countries across five continents. He’s dedicated himself to helping others ...
Clinical & Scientific Conference, researchers and clinicians are talking about the central role of patients, families, and caregivers in driving change for people living with neuromuscular diseases.
Columnist Juliet Taylor reflects on the legacy of Leah Stavenhagen, who founded Her ALS Story for young women diagnosed with the disease.
Hearing how a family found meaning in the midst of their loss reminds columnist Kristin Neva that she isn't alone in her grief with ALS.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results